Dadun/></a>
				</td>
				<td class= Dadun
   (New user)
Help  | Contact  |  Castellano English  
 

Dadun > Depósito Académico > Clínica Universidad de Navarra > Pediatría > DA - CUN - Pediatría - Artículos de revista >

CDH11 Expression is Associated with Survival in Patients with Osteosarcoma
Authors: Nakajima, G. (Go)
Patiño, A. (Ana)
Bruheim, S. (Skjalg)
Xi, Y. (Yaguang)
San-Julian, M. (Mikel)
Lecanda, F. (Fernando)
Sierrasesumaga, L. (Luis)
Muller, C. (Christoph)
Fodstad, O. (Oystein)
Ju, J. (Jingfang)
Keywords: Bone Neoplasms/genetics/metabolism/mortality
Cadherins/genetics/metabolism
Osteosarcoma/genetics/metabolism/mortality
Issue Date: 2008
Publisher: International Institute of Anticancer Research
Publisher version: http://cgp.iiarjournals.org/content/5/1/37.long
ISSN: 1109-6535
Citation: Nakajima G, Patino-Garcia A, Bruheim S, Xi Y, Julian MS, Lecanda F, et al. CDH11 Expression is Associated with Survival in Patients with Osteosarcoma. Cancer Genomics - Proteomics January-February 2008 January-February 2008;5(1):37-42.
Abstract
Previous studies have shown that cadherin-11 (CDH11) may be involved in the metastatic process of osteosarcoma. The correlation of the expression levels of CDH11 in osteosarcoma samples with the risk of disease progression and metastasis was examined. Real time qRT-PCR was used to quantify CDH11 expression in a set of newly established osteosarcoma cell lines, 11 primaries and five metastases, compared to the levels in 12 normal osteoblast cell lines established from healthy bone, and also in a set of 10 snap-frozen osteosarcoma samples. In all cases long term clinical follow-up data was available. The CDH11 expression level decreased gradually from the osteoblast to the primary cell lines (p=0.2184) and further to those established from the tumor metastases (p=0.0275). Importantly, the level of CDH11 expression correlated significantly (p=0.01) with patient survival (Kaplan-Meier survival analysis) in both sample sets (p=0.0128 for the cell lines, p=0.0492 for the biopsies). In conclusion, the results indicate that CDH11 may be useful as a prognostic marker of disease progression and survival in osteosarcoma.
Permanent link: http://hdl.handle.net/10171/23749
Appears in Collections:DA - CIMA - Oncología - Adhesión y metástasis - Artículos de revista
DA - CUN - Pediatría - Artículos de revista

Files in This Item:
File:  Cancer Genomics Proteomics.2008.37.pdf
Description: 
Size:  212,2 kB
Format:  Adobe PDF
 View / Open 

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.